相似文献
1
Encapsulation of a radiolabeled cluster inside a fullerene cage, (177)Lu(x)Lu((3-x))N@C(80): an interleukin-13-conjugated radiolabeled metallofullerene platform.
J Am Chem Soc. 2010 Apr 14;132(14):4980-1. doi: 10.1021/ja9093617.
2
Reactivity of metallic nitride endohedral metallofullerene anions: electrochemical synthesis of a Lu3N@Ih-C80 derivative.
J Am Chem Soc. 2011 Mar 2;133(8):2760-5. doi: 10.1021/ja110160j. Epub 2011 Feb 3.
3
A New Interleukin-13 Amino-Coated Gadolinium Metallofullerene Nanoparticle for Targeted MRI Detection of Glioblastoma Tumor Cells.
J Am Chem Soc. 2015 Jun 24;137(24):7881-8. doi: 10.1021/jacs.5b03991. Epub 2015 Jun 11.
4
Lu-Labeled Albumin-Binder-Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio.
J Nucl Med. 2021 Apr;62(4):521-527. doi: 10.2967/jnumed.120.250738. Epub 2020 Aug 28.
5
Redox properties of mixed lutetium/yttrium nitride clusterfullerenes: endohedral Lu(x)Y(3-x)N@C80(I) (x = 0-3) compounds.
Chemphyschem. 2009 May 11;10(7):1037-43. doi: 10.1002/cphc.200800811.
6
Full exploration of the Diels-Alder cycloaddition on metallofullerenes M3N@C80 (M = Sc, Lu, Gd): the D(5h) versus I(h) isomer and the influence of the metal cluster.
Chemistry. 2012 Jul 16;18(29):8944-56. doi: 10.1002/chem.201200940. Epub 2012 Jun 12.
7
Preparation and Evaluation of Lu-Labeled Gemcitabine: An Effort Toward Developing Radiolabeled Chemotherapeutics for Targeted Therapy Applications.
Cancer Biother Radiopharm. 2017 Sep;32(7):239-246. doi: 10.1089/cbr.2017.2255. Epub 2017 Sep 6.
8
AAZTA-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for Lu-labeling of monoclonal antibodies under mild conditions.
Nucl Med Biol. 2021 May-Jun;96-97:80-93. doi: 10.1016/j.nucmedbio.2021.03.007. Epub 2021 Mar 26.
9
Experimental half-life determination of ¹⁷⁶Lu.
Appl Radiat Isot. 2013 Nov;81:140-5. doi: 10.1016/j.apradiso.2013.03.033. Epub 2013 Mar 22.
10
Fluorescent, Plasmonic, and Radiotherapeutic Properties of the Lu-Dendrimer-AuNP-Folate-Bombesin Nanoprobe Located Inside Cancer Cells.
Mol Imaging. 2017 Jan 1;16:1536012117704768. doi: 10.1177/1536012117704768.
引用本文的文献
1
Pb in targeted radionuclide therapy: a review.
EJNMMI Radiopharm Chem. 2025 Jul 1;10(1):34. doi: 10.1186/s41181-025-00362-7.
2
Water-soluble endohedral metallofullerenes: new horizons for biomedical applications.
Chem Commun (Camb). 2023 Nov 14;59(91):13551-13561. doi: 10.1039/d3cc03603k.
3
Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology.
Bioengineering (Basel). 2023 Jan 12;10(1):108. doi: 10.3390/bioengineering10010108.
4
The Preparation, Biodistribution, and Dosimetry of Encapsulated Radio-Scandium in a Dendrimer for Radio-nano-pharmaceutical Application.
Iran J Pharm Res. 2022 May 8;21(1):e126912. doi: 10.5812/ijpr-126912. eCollection 2022 Dec.
5
Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications.
Int J Mol Sci. 2022 Jan 31;23(3):1641. doi: 10.3390/ijms23031641.
6
Interactions between Endohedral Metallofullerenes and Proteins: The Gd@C-Lysozyme Model.
ACS Omega. 2018 Oct 22;3(10):13782-13789. doi: 10.1021/acsomega.8b01888. eCollection 2018 Oct 31.
7
Dosimetry of Ytterbium-poly (amidoamine) Therapy for Humans' Organs.
J Med Phys. 2018 Jul-Sep;43(3):173-178. doi: 10.4103/jmp.JMP_8_18.
8
Magnetic resonance molecular imaging for non-invasive precision cancer diagnosis.
Curr Opin Biomed Eng. 2017 Sep;3:67-73. doi: 10.1016/j.cobme.2017.11.003. Epub 2017 Nov 16.
9
Efficient Uptake of Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy.
Angew Chem Int Ed Engl. 2018 Jan 2;57(1):218-222. doi: 10.1002/anie.201710232. Epub 2017 Nov 30.
10
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.
Nat Commun. 2017 Sep 25;8(1):692. doi: 10.1038/s41467-017-00741-y.
本文引用的文献
1
Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity.
Bioconjug Chem. 2009 Jun;20(6):1186-93. doi: 10.1021/bc900051d.
2
Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent.
Bioconjug Chem. 2008 Mar;19(3):651-5. doi: 10.1021/bc7002742. Epub 2008 Feb 7.
3
Medicinal applications of fullerenes.
Int J Nanomedicine. 2007;2(4):639-49.
4
(212)Pb@C(60) and its water-soluble derivatives: synthesis, stability, and suitability for radioimmunotherapy.
J Am Chem Soc. 2007 Apr 25;129(16):5131-8. doi: 10.1021/ja068639b. Epub 2007 Mar 30.
5
Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas.
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1388-95. doi: 10.1007/s00259-006-0351-8. Epub 2007 Jan 31.
6
In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle.
Radiology. 2006 Sep;240(3):756-64. doi: 10.1148/radiol.2403051341. Epub 2006 Jul 12.
7
Purification of endohedral trimetallic nitride fullerenes in a single, facile step.
J Am Chem Soc. 2005 Nov 23;127(46):16292-8. doi: 10.1021/ja055089t.
8
Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.
Neoplasia. 2004 Jan-Feb;6(1):15-22. doi: 10.1016/s1476-5586(04)80049-6.
9
IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
Neoplasia. 2002 Sep-Oct;4(5):388-99. doi: 10.1038/sj.neo.7900234.
10
Therapeutic radiopharmaceuticals.
Chem Rev. 1999 Sep 8;99(9):2269-92. doi: 10.1021/cr9804386.
Zotero 插件